Disorders of immune reconstitution in patients with HIV infection responding to antiretroviral therapy

被引:76
作者
French M.A. [1 ]
机构
[1] Department of Clinical Immunology, Royal Perth Hospital, Perth, WA 6847
关键词
Immune Reconstitution; Thyroid Stimulate Hormone Receptor; Immune Reconstitution Syndrome; Immune Restoration Disease; Immune Recovery Uveitis;
D O I
10.1007/s11904-007-0003-z
中图分类号
学科分类号
摘要
Patients with HIV infection who were very immunodeficient before achieving a virologic response to antiretroviral therapy (ART) may experience various disorders of immune reconstitution. Immune restoration disease occurs in approximately 10% to 50% of patients and results from the restoration of a pathogen-specific immune response that causes immunopathology and presents as tissue inflammation or cellular proliferative disease. Opportunistic infections occur in no more than 5% of patients, but approximately one half of these patients have higher than expected CD4 T-cell counts and appear to have residual immune dysfunction. Autoimmune disease may arise because the reconstituted immune system confers an increased susceptibility to immune dysregulation but there may be different mechanisms because Graves' disease presents after a median time of about 2 years of ART whereas systemic lupus erythematosus presents earlier. Persistent CD4 T-cell deficiency (< 500/μL) affects up to 60% of patients and appears to reflect depletion of the naïve T-cell pool that results from low production and/or increased turnover of cells. Copyright © 2007 by Current Medicine Group LLC.
引用
收藏
页码:16 / 21
页数:5
相关论文
共 58 条
[1]  
Stone S.F., Price P., French M.A., Cytomegalovirus (CMV)-specific CD8+ T cells in individuals with HIV infection: Correlation with protection from CMV disease, J Antimicrob Chemother, 57, pp. 585-588, (2006)
[2]  
French M.A., Lenzo N., John M., Et al., Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy, HIV Med, 1, pp. 107-115, (2000)
[3]  
French M.A., Price P., Stone S.F., Immune restoration disease after antiretroviral therapy, AIDS, 18, pp. 1615-1627, (2004)
[4]  
Schrier R.D., Song M.K., Smith I.L., Et al., Intraocular viral and immune pathogenesis of immune recovery uveitis in patients with healed cytomegalovirus retinitis, J Ret Vitreous Dis, 26, pp. 165-169, (2006)
[5]  
Stone S.F., Price P., Tay-Kearney M.-L., French M.A., Cytomegalovirus (CMV) retinitis immune restoration disease occurs during HAART-induced restoration of CMV-specific immune responses within a predominant Th2 cytokine environment, J Infect Dis, 185, pp. 1813-1817, (2002)
[6]  
Stone S.F., Lee S., Keane N.M., Et al., Association of increased hepatitis C virus (HCV)-specific IgG and soluble CD26 (dipeptidyl peptidase IV) enzyme activity with hepatotoxicity after highly active antiretroviral therapy in human immunodeficiency virus-HCV-coinfected patients, J Infect Dis, 186, pp. 1498-1502, (2002)
[7]  
Connick E., Kane M.A., White I.E., Et al., Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma during potent antiretroviral therapy, Clin Infect Dis, 39, pp. 1852-1855, (2004)
[8]  
Phillips P., Bonner S., Gataric N., Et al., Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: Spectrum of disease and long-term follow-up, Clin Infect Dis, 41, pp. 1483-1497, (2005)
[9]  
Bower M., Nelson M., Young A.M., Et al., Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma, J Clin Oncol, 23, pp. 5224-5228, (2005)
[10]  
Lawn S.D., Bekker L.G., Miller R.F., Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals, Lancet Infect Dis, 5, pp. 361-373, (2005)